Prolonged progression-free survival achieved by octreotide LAR plus transarterial embolization in low-to-intermediate grade neuroendocrine tumor liver metastases with high hepatic tumor burden.
Sign Up to like & getrecommendations! Published in 2022 at "Cancer medicine"
DOI: 10.1002/cam4.4628
Abstract: OBJECTIVE To evaluate the efficacy and outcome of transarterial embolization (TAE) plus octreotide long-acting repeatable (LAR) on patients with low-to-intermediate neuroendocrine tumor liver metastases (NETLM). METHODS One hundred and sixteen patients with G1/G2 NETLM treated… read more here.
Keywords: tumor; response; neuroendocrine tumor; transarterial embolization ... See more keywords
The Landmark Series: Neuroendocrine Tumor Liver Metastases
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-020-08787-x
Abstract: Background Neuroendocrine tumors are becoming increasingly prevalent, with many patients presenting with or developing metastatic disease to the liver. Methods In this landmark series paper, we highlight the critical studies that have defined the surgical… read more here.
Keywords: tumor liver; neuroendocrine tumor; landmark series; liver ... See more keywords
Laparoscopic treatment of inflammatory myofibroblastic tumor in liver: A case report
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v10.i32.11853
Abstract: BACKGROUND Inflammatory myofibroblastic tumor in the liver (IMTL) is a rare borderline mesenchymal tumor. Neither clinical symptoms nor laboratory tests have absolute specificity for the diagnosis of IMTL, and imaging also lacks obvious specificity. Although… read more here.
Keywords: tumor liver; liver; myofibroblastic tumor; inflammatory myofibroblastic ... See more keywords
Microwave ablation combined with hepatectomy for treatment of neuroendocrine tumor liver metastases
Sign Up to like & getrecommendations! Published in 2021 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v9.i19.5064
Abstract: BACKGROUND Hepatectomy is the first choice for treating neuroendocrine tumor liver metastases. However, most patients with neuroendocrine tumor liver metastases are not suitable for hepatectomy. Ablation combined with hepatectomy can be an alternative to liver… read more here.
Keywords: tumor liver; neuroendocrine tumor; liver; ablation combined ... See more keywords